Evaluation of the efficacy and safety of two different linvoseltamab Phase 2 dose regimens: results from LINKER-MM1

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览4
暂无评分
关键词
different linvoseltamab phase,dose regimens,efficacy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要